Literature DB >> 23199819

A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.

Eugene J Carragee, Ray M Baker, Edward C Benzel, Stanley J Bigos, Ivan Cheng, Terry P Corbin, Richard A Deyo, Eric L Hurwitz, Jeffrey G Jarvik, James D Kang, Jon D Lurie, Thomas E Mroz, F Cumhur Oner, Wilco C Peul, James Rainville, John K Ratliff, Jeffrey A Rihn, David J Rothman, Mark L Schoene, Dan M Spengler, Bradley K Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23199819     DOI： 10.1016/j.spinee.2012.11.002

Source DB:  PubMed          Journal:  Spine J        ISSN： 1529-9430            Impact factor:   4.166


× No keyword cloud information.
  18 in total

Review 1.  Cell-based approaches to the engineering of vascularized bone tissue.

Authors:  Rameshwar R Rao; Jan P Stegemann
Journal:  Cytotherapy       Date:  2013-08-31       Impact factor: 5.414

2.  Antibiotics a cure for back pain, a false dawn or a new era?

Authors:  John O'Dowd; Adrian Casey
Journal:  Eur Spine J       Date:  2013-07-12       Impact factor: 3.134

3.  Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States.

Authors:  Lifeng Lao; Jeremiah R Cohen; Elizabeth L Lord; Zorica Buser; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2015-05-24       Impact factor: 3.134

4.  How do you know it is true? Integrity in research and publications: AOA critical issues.

Authors:  Joseph A Buckwalter; Vernon T Tolo; Regis J O'Keefe
Journal:  J Bone Joint Surg Am       Date:  2015-01-07       Impact factor: 5.284

Review 5.  Stem cells for spine surgery.

Authors:  Joshua Schroeder; Janina Kueper; Kaplan Leon; Meir Liebergall
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

6.  Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?

Authors:  Sohaib Hashmi; Mohamed Noureldin; Safdar N Khan
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

Review 7.  The potential impact of bone tissue engineering in the clinic.

Authors:  Ruchi Mishra; Tyler Bishop; Ian L Valerio; John P Fisher; David Dean
Journal:  Regen Med       Date:  2016-08-23       Impact factor: 3.806

Review 8.  The role of stem cell therapies in degenerative lumbar spine disease: a review.

Authors:  David Oehme; Tony Goldschlager; Jeffrey V Rosenfeld; Peter Ghosh; Graham Jenkin
Journal:  Neurosurg Rev       Date:  2015-03-07       Impact factor: 3.042

9.  Multipotential stromal cell abundance in cellular bone allograft: comparison with fresh age-matched iliac crest bone and bone marrow aspirate.

Authors:  Thomas G Baboolal; Sally A Boxall; Yasser M El-Sherbiny; Timothy A Moseley; Richard J Cuthbert; Peter V Giannoudis; Dennis McGonagle; Elena Jones
Journal:  Regen Med       Date:  2014-03-12       Impact factor: 3.806

10.  Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.

Authors:  Adam P Goode; William J Richardson; Robin M Schectman; Timothy S Carey
Journal:  Spine J       Date:  2013-12-07       Impact factor: 4.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.